sorbitol has been researched along with Hyperlipemia in 12 studies
D-glucitol : The D-enantiomer of glucitol (also known as D-sorbitol).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Diabetes mellitus is an important risk factor for coronary heart disease and cerebral vascular disease." | 1.29 | [Diabetes mellitus as a risk factor for arteriosclerosis]. ( Kasuga, M; Maeda, E; Yoshino, G, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (58.33) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakatsu, Y | 1 |
| Kokubo, H | 1 |
| Bumdelger, B | 1 |
| Yoshizumi, M | 1 |
| Yamamotoya, T | 1 |
| Matsunaga, Y | 1 |
| Ueda, K | 1 |
| Inoue, Y | 1 |
| Inoue, MK | 1 |
| Fujishiro, M | 1 |
| Kushiyama, A | 1 |
| Ono, H | 1 |
| Sakoda, H | 1 |
| Asano, T | 1 |
| Yamada, N | 1 |
| Fujita, T | 1 |
| EDGREN, B | 1 |
| WRETLIND, A | 1 |
| Lim, KH | 1 |
| Lian, WB | 1 |
| Yeo, CL | 1 |
| Schulze, J | 1 |
| Julius, U | 1 |
| Hanefeld, M | 1 |
| Haller, H | 1 |
| Leonhardt, W | 1 |
| Maeda, E | 1 |
| Yoshino, G | 1 |
| Kasuga, M | 1 |
| Steiner, G | 1 |
| Wilson, D | 1 |
| Vranic, M | 1 |
| Avogaro, P | 1 |
| Bittolo-Bon, G | 1 |
| Cazzolato, G | 1 |
| Brunzell, JD | 1 |
| Berg, G | 1 |
| Matzkies, F | 1 |
| Bode, JC | 1 |
4 reviews available for sorbitol and Hyperlipemia
| Article | Year |
|---|---|
[Molecular mechanisms of diabetic atherosclerosis].
Topics: Arteriosclerosis; Diabetes Complications; Glycation End Products, Advanced; Humans; Hyperinsulinism; | 2002 |
[Expression mechanisms and incident factors of diabetic nephropathy].
Topics: Animals; Cytokines; Diabetic Nephropathies; Fructose; Genetic Predisposition to Disease; Glomerular | 2002 |
THE THEORETICAL BACKGROUND OF THE INTRAVENOUS NUTRITION WITH FAT EMULSIONS.
Topics: Anemia; Blood Coagulation Disorders; Blood Pressure; Cottonseed Oil; Egg Yolk; Emulsions; Fats; Fatt | 1963 |
Use of fructose, sorbitol, or xylitol as a sweetener in diabetes mellitus.
Topics: Arteriosclerosis; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Dietary Carbohydrates; D | 1978 |
2 trials available for sorbitol and Hyperlipemia
| Article | Year |
|---|---|
Effect of sorbinicate (nicotinic hexaester of D-glucitol) on the plasma FFA; plasma levels of nicotinic acid after sorbinicate administration.
Topics: Adult; Clinical Trials as Topic; Fatty Acids, Nonesterified; Humans; Hyperlipidemias; Male; Middle A | 1978 |
[Serum lipoproteids and ketone bodies after constant infusion of sorbitol i.v. (author's transl)].
Topics: Acetoacetates; Dose-Response Relationship, Drug; Glycerophosphates; Gout; Humans; Hydroxybutyrates; | 1975 |
6 other studies available for sorbitol and Hyperlipemia
| Article | Year |
|---|---|
The SGLT2 Inhibitor Luseogliflozin Rapidly Normalizes Aortic mRNA Levels of Inflammation-Related but Not Lipid-Metabolism-Related Genes and Suppresses Atherosclerosis in Diabetic ApoE KO Mice.
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Cell Adhesion Molecules; Cytokines; Diabetes Mel | 2017 |
Does visual turbidity correlate with serum triglyceride levels in babies on total parenteral nutrition?
Topics: Drug Combinations; Fat Emulsions, Intravenous; Gestational Age; Humans; Hyperlipidemias; Infant, New | 2006 |
[Therapy of hypertriglyceridemia from a pathophysiological viewpoint].
Topics: Clofibrate; Diet, Reducing; Drug Combinations; Exercise Therapy; Humans; Hyperlipidemias; Phospholip | 1981 |
[Diabetes mellitus as a risk factor for arteriosclerosis].
Topics: Arteriosclerosis; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Glycosylation; H | 1993 |
Studies of glucose turnover and renal function in an unusual case of hereditary fructose intolerance.
Topics: Administration, Oral; Carbohydrate Metabolism, Inborn Errors; Diabetes Complications; Fructose; Fruc | 1977 |
[Metabolic disorders caused by intravenous administration of sorbitol or fructose].
Topics: Acidosis; Adenosine Triphosphate; Administration, Oral; Fructose; Gout; Humans; Hyperlipidemias; Hyp | 1973 |